BioCentury
ARTICLE | Financial News

AxoGen raises $123M in upsized follow-on

May 9, 2018 6:07 PM UTC

AxoGen Inc. (NASDAQ:AXGN) raised $123 million through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is a 5% discount to AxoGen’s close of $43.15 on May 7, when the company proposed after hours to sell 2 million shares.

AxoGen markets a portfolio of products for peripheral nervous system repair, including the AVANCE nerve graft, which comprises decellularized allograft nerves recovered from cadaveric donors. ...

BCIQ Company Profiles

Axogen Ltd.